Navigation Links
Advanced Bio-Technologies Inc Announces Acquisition by HealthEdge Investment Partners, Tampa FL
Date:9/26/2007

CLEARWATER, Fla., Sept. 26 /PRNewswire/ -- Advanced Bio-Technologies Inc (ABT) is pleased to announce that the majority shares in the corporation have been purchased by HealthEdge Investment Partners of Tampa FL. (http://www.healthedgepartners.com).

Paul Guilbaud, ABT President and CEO, commented, "This is a new stage in the exciting development of ABT. The acquisition allows us to ramp up sales and marketing in the USA, build the necessary infrastructure for our world- wide sales expansion and allow us to support our International distributors."

"This is a positive development for both ABT and HealthEdge. We believe that the synergy between our fund and the company will facilitate accelerated growth for the company. We intend to work closely with the management of ABT to grow the business organically and by using the infrastructure as a platform to acquire new brands," commented Brian Anderson, Managing Partner at HealthEdge Investment Partners.

Advanced Bio-Technologies is one of the leading companies in the rapidly growing global scar treatment market with its patented silicone-based products marketed under the brand Kelo-cote(R). Silicone is recognized as the first line of treatment for abnormal scars throughout the medical community. ABT has relocated its offices to Clearwater, Florida, where it will centralize the functions of the company to better manage its growth.

ABT has also launched its Kelo-cote(R) scar treatment line in the key European markets through 100%-owned subsidiaries in the UK and Germany. This strategic development allows ABT to have direct operations in some of the largest markets worldwide, and creates the platform for concentrating its efforts in the Plastic Surgery and Dermatology sectors. New products will ensure growth for ABT in each of those markets. "We have established a strong Kelo-cote(R) presence in the New York City, Los Angeles and Miami markets and are currently expanding our US sales team to reach other key metro areas including Tampa, Dallas, and Atlanta," stated Mr. Guilbaud.


'/>"/>
SOURCE Advanced Bio-Technologies Inc
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Achieving Reliable Protein Quantitation Results Using ICAT Reagents, MALDITOF Mass Spectrometry, and Advanced Data Interpretation Tool
2. Precision Testing for the Sciclone Advanced Liquid Handler Z8 Option
3. 384 Well Pipetting Precision and Accuracy Testing Using the Sciclone Advanced Liquid Handler
4. WARF expands license agreement with Advanced Cell Technology
5. Rockwells $1M gift to UWM will support advanced automation research
6. Advanced CIO: Technology execs must trumpet their success
7. FDA approves advanced digital mammography system
8. Tech Digest: Inacom; St. Michaels, St. Clares hospitals; Merge eMed; Advanced Data-Comm; Blue Cross and Blue Shield
9. Wisconsins insurance companies use advanced IT to speed relief
10. $60 Million Available in Advanced Tech Competition
11. Advanced Life Sciences to Hit the Road For $30 Million in Funding
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... -- VMS BioMarketing, a leading provider of patient support solutions, has ... (CNE) network, which will launch this week. The VMS CNEs ... professionals to enhance the patient care experience by delivering peer-to-peer ... care professionals to help women who have been diagnosed and ... ...
(Date:10/11/2017)... ... October 11, 2017 , ... Singh Biotechnology today announced ... to SBT-100, its novel anti-STAT3 (Signal Transducer and Activator of Transcription 3) B ... to cross the cell membrane and bind intracellular STAT3 and inhibit its function. ...
(Date:10/10/2017)... ... ... Dr. Bob Harman, founder and CEO of VetStem Biopharma, Inc. ... event entitled “Stem Cells and Their Regenerative Powers,” was held on August 31st, ... was joined by two human doctors: Peter B. Hanson, M.D., Chief of Orthopedic Surgery, ...
(Date:10/10/2017)... , ... October 10, 2017 , ... ... of 13 prestigious awards honoring scientists who have made outstanding ... a scheduled symposium during Pittcon 2018, the world’s leading conference and exposition for ...
Breaking Biology Technology:
(Date:4/13/2017)... According to a new market research report "Consumer IAM Market by ... Service, Authentication Type, Deployment Mode, Vertical, and Region - Global Forecast to ... USD 14.30 Billion in 2017 to USD 31.75 Billion by 2022, at ... ... MarketsandMarkets Logo ...
(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/3/2017)...  Data captured by IsoCode, IsoPlexis Corporation,s ... statistically significant association between the potency of ... objective response of cancer patients post-treatment. The ... cancer patients will respond to CAR-T cell ... to improve both pre-infusion potency testing and cell ...
Breaking Biology News(10 mins):